Back to Journals » Cancer Management and Research » Volume 12

Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions

Total article views   HTML views PDF downloads Totals
4,441 Dovepress* 3,960+ 665 4,625
PubMed Central* 481 178 659
Totals 4,441 843 5,284
*Since 2 November 2020
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar